Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.

Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:


Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

CompanyDrug NameStatusIndication Group
Paladin Labs Oxytrol Approved in CanadaGenito urinary system & sex hormones
Pain Therapeutics Oxytrex in Phase IIINervous system
Cardiome pharma Oxyprim Approved in USAAlimentary tract & metabolism
United Therapeutics OvaRex in Phase IIIAntineoplastic & immunomodulating agents
Anika Therapeutics ORTHOVISC Approved in USAMusculoskeletal system
Bristol-Myers Squibb ORENCIA Approved in USA and CanadaMusculoskeletal system
DOR BioPharma orBec Submitted for approval in EUAlimentary tract & metabolism
Nobex Oratonin accomplished Phase IMusculoskeletal system
SuperGen Orathecin discontinuedAntineoplastic & immunomodulating agents
YM BioSciences ORATAQ accomplished Phase IAntineoplastic & immunomodulating agents
Allergy Therapeutics OralvacB2MPL in Phase IAntineoplastic & immunomodulating agents
Generex Biotechnology Oral-lyn Approved in Ecuador, In Phase IIIAlimentary tract & metabolism
PediaMed Oralgam in Phase IINervous system
Access OralDisc A Approved in USAAnti-infectives for systemic use
Nobex Oral APAZA in Phase IIAlimentary tract & metabolism
CollaGenex Oracea Approved in USADermatologicals
MacroChem Opterone accomplished Phase IGenito urinary system & sex hormones
Endo Opana Approved in USANervous system
Endo Opana Approved in USANervous system
Antigenics Oncophage discontinuedAntineoplastic & immunomodulating agents

Drug Pipeline Copyright © 2005- 2018 All Rights Reserved.